AzTrials
AzTrials

Cancer PainEDICAPNCT06791213

Effectiveness of the Digital Multimedia Health Education in Improving Cancer Pain, Analgesic Adherence, and Pain Control Satisfaction With Cancer Patient

A study testing Digital Multimedia Health Education in people with Cancer Pain, run by National Taiwan University Hospital at 1 site in Taiwan.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

According to the International Association for the Study of Pain (IASP), pain is an unpleasant sensory and emotional experience associated with, or resembling that associated with, actual or potential tissue damage . Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Cancer Pain
What is being tested?
Digital Multimedia Health Education
Could I receive a placebo?
No, everyone receives an active treatment
How many people
98 participants
Where
1 siteTaiwan
Study dates
1 Apr 2025to 1 Nov 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Adults aged over 18 years.
  • Diagnosed with a solid tumor and reporting a pain score of 4 or higher.
  • Patients using prescribed strong opioid medications for pain management.
  • Conscious, capable of communicating in Mandarin, understanding Mandarin, or -Able to write in text.
  • Able to operate electronic devices (e.g., smartphones, tablets, or computers) independently, or with assistance from family members or caregivers.

Who cannot join

  • Patients with visual or auditory impairments.
  • Patients with cognitive impairments.
  • Diagnosed by a physician as having substance addiction (addictive substances include central nervous system depressants: opioids, heroin, ketamine; central nervous system stimulants: amphetamines, ecstasy, cocaine; and central nervous system hallucinogens: cannabis).

Trial locations and contacts

1 site in 1 country.

Taiwan1 site
  • 13F., No. 119, Ln. 136, Sec. 3, Zhongshan Rd., Zhonghe Dist., New Taipei City 235 , Taiwan (R.O.C.)

    New Taipei City, 235

    MINCHIA WENG, 0963320637, mjsmile0523@gmail.com

    MIN CHIA WENG

Other trials in Taiwan

About this study

According to the International Association for the Study of Pain (IASP), pain is an unpleasant sensory and emotional experience associated with, or resembling that associated with, actual or potential tissue damage . Despite advances in precision medicine, pain remains a common complaint among cancer patients, with 44.5% reporting pain and a 30.6% prevalence of moderate to severe pain. In Taiwan, over half of cancer patients experience pain in the week leading up to their outpatient visit, with 54% of oncology outpatients reporting pain issues. Of these, only 58% receive analgesics, with more medications given to those with worsening conditions. Pain significantly affects sleep, and over 50% of patients feel pain despite analgesic control. Research indicates that Asian patients often view cancer negatively, avoiding discussions about their condition, which normalizes their pain and potentially worsens it.

Enhancing patient self-efficacy can increase satisfaction with pain management, and it is recommended that healthcare professionals develop interventions to improve pain management satisfaction. Self-management interventions have shown effectiveness in improving pain-related knowledge and quality of life. These interventions can encompass patient attitudes and knowledge, with guidance and consultation from nurses reinforcing information about pain management and medication adherence.

Read more

In clinical settings, nurses may be too busy to provide comprehensive and consistent health education, leading to insufficient patient understanding of medications. Digital multimedia health education tools, which use visual aids, can better capture patients' attention and facilitate unrestricted learning regardless of time or place, leading to improved learning outcomes.

This study aims to investigate the effectiveness of "digital multimedia" in reducing pain, enhancing medication adherence, and improving pain control satisfaction among patients. The goal is to overcome the limitations of busy healthcare providers, allowing patients to learn independently, understand pain and analgesic use, dispel myths about pain medications, and enhance pain control, ultimately improving self-care capabilities, pain control satisfaction, and quality of life.

Conditions
Cancer Pain
Being tested
Digital Multimedia Health Education
Keywords
Cancer Pain, Digital Multimedia Health Education, Analgesic Adherence, Pain Control Satisfaction
Medical subject headings
Cancer Pain

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Digital Multimedia Health EducationOther

    This study aims to investigate the effectiveness of "digital multimedia" in reducing pain, enhancing medication adherence, and improving pain control satisfaction among patients. The goal is to overcome the limitations of busy healthcare providers, allowing patients to learn independently, understand pain and analgesic use, dispel myths about pain medications, and enhance pain control, ultimately improving self-care capabilities, pain control satisfaction, and quality of life.

Study groups in NCT06791213
Study groupRoleWhat they receive
Treatment groupExperimentalDigital Multimedia Health Education
Receives: Other: Digital Multimedia Health Education
Control groupNo interventionNot described

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Cancer pain

    This study defines its operational terms using the Taiwanese version of the Brief Pain Inventory (BPI-T). Pain is assessed through the Numerical Rating Scale (NRS), which evaluates pain severity on a scale ranging from 0 to 10. Higher scores indic.

    Measured: From enrollment to the end of treatment at 12 weeks

  2. Analgesic Adherence

    1. Calculate the total amount of pain medication consumed by patients and the total amount prescribed by physicians to determine the medication adherence percentage. Additionally, convert opioid prescriptions into morphine-equivalent doses to calculate the medication adherence percentage.
    2. The 4-item Morisky Medication Adherence Scale (MMAS-4) was used for assessment. This structured measurement scale was originally developed by Morisky et al. (1986) and consists of four questions. The MMAS-4 scores indicate medication adherence, with higher scores representing greater adherence to prescribed medication.

    Measured: From enrollment to the end of treatment at 12 weeks

  3. Pain Control Satisfaction

    The Pain Treatment Satisfaction Scale (PTSS) was adopted for psychometric assessment and validation in patients with acute and chronic pain. The scale evaluates various aspects, including pain severity, information about pain and its treatment, medication therapy, the effects of current pain medications, the route of administration, medication side effects, and satisfaction with current pain medications and overall care.

    Measured: From enrollment to the end of treatment at 12 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted24 Jan 2025
  2. Study start1 Apr 2025 (estimated)
  3. Primary completion1 Oct 2025 (estimated)
  4. Study completion1 Nov 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
98 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06791213
Sponsor's protocol ID
202407158RINE
Acronym
EDICAP
Status last verified
Oct 2024
First submitted
13 Jan 2025
Last updated
19 Mar 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Digital Multimedia Health Education in people with Cancer Pain, run by National Taiwan University Hospital at 1 site in Taiwan.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 19 Mar 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Taiwan. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact MINCHIA WENG (886-963-320-637, mjsmile0523@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Cancer pain (time frame: From enrollment to the end of treatment at 12 weeks). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 Mar 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in